Status:
TERMINATED
Rhabdomyosarcoma and Malignant Soft Tissue Tumours of Childhood
Lead Sponsor:
Gustave Roussy, Cancer Campus, Grand Paris
Conditions:
Rhabdomyosarcoma
Malignant Soft Tissue
Eligibility:
All Genders
6-21 years
Phase:
PHASE3
Brief Summary
Objective of the study objectives was to explore survival advantage for an intensified chemotherapy strategy in a randomised trial. IVA (ifosfamide, vincristine, actinomycin D) or a 6 drug combinatio...
Eligibility Criteria
Inclusion
- age \> 6 months and \< 18 years
- no distant metastases
- diagnosis within previous 8 weeks without prior treatment except surgery
- pathology available for central review
- written consent according to institutional requirement
Exclusion
- stage III (node positive)
- stage I or II non alveolar orbital tumours
- patients with parameningeal disease aged \< 3 years
Key Trial Info
Start Date :
July 1 1995
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00162695
Start Date
July 1 1995
Last Update
September 13 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Gustave Roussy
Villejuif, France, 94800